Dr. Reddy's Launches Sputnik V Vaccine In India
Bio Spectrum|June 2021
Dr. Reddy’s Laboratories announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on May 1, 2021, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13, 2021. As part of a limited pilot, the soft launch of the vaccine has commenced and the first dose of the vaccine was administered in Hyderabad on May 14, 2021.

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM BIO SPECTRUMView All

“Our allergic rhinitis drug is technologically superior, masks bitterness and 52% cheaper”

Alok Malik, Group Vice President & Head, India Formulations, Glenmark Pharmaceuticals, Mumbai

5 mins read
Bio Spectrum
August 2021

Techade REDEFINING FUTURE OF life sciences industry

Digital transformation is the topmost priority for global corporations and in a highly connected world that will remain largely contactless for an extended period, there are shifts in business models, customer experience, operations, and employee experience. With technology adoption accelerating across sectors, 2021 is likely to put the spotlight on the emergence of growth verticals in the life sciences sector namely healthcare, pharma, medical devices, diagnostics etc. India is now standing at the cusp of a re-imagined decade of technology, commonly being referred to as ‘Techade’. While we anticipate a significantly better global economic growth this year as compared to 2020, we are also very much looking forward to the enhancement being brought to the Indian life sciences industry as it continues its transformation journey in this redefined techade.

10+ mins read
Bio Spectrum
August 2021

Multifarious Cataract cures emerge

Being documented as India’s most significant cause of bilateral blindness that is for both eyes, cataract has become an economic and social burden that is increasing with the ageing population.

3 mins read
Bio Spectrum
August 2021

WHO Updates Guidelines For TB Detection

The World Health Organization (WHO) has issued an update to its consolidated guidelines on the detection of tuberculosis (TB) and drug-resistant TB.

1 min read
Bio Spectrum
August 2021

Is The 5G Health Scare Unfounded?

The introduction of the 5G network has been mired in numerous controversies. Governments across the globe, activists and telecom operators are embroiled in a bitter fight, filing lawsuits and protesting in large numbers. Although most of the available research on electromagnetic fields (EMF) reveals that there are no harmful effects from mobile radiation, some studies do reveal that it has the potential to damage the very structure of the DNA. Cancer, impaired reproductive health and numerous other disorders, including psychiatric, have been attributed to 5G. Will the implementation of the 5G network have serious health implications, or are these fears unfounded? We try to weigh-in the opposing sides.

8 mins read
Bio Spectrum
August 2021

Is Antibody Cocktail Offering The Right Mix?

Although the clinical outcomes, as well as clinical trials, have been very promising for patients treated with the antibody cocktail so far, the Delta plus variant is considered to be resistant to the monoclonal antibody (mAb) cocktail treatment.

6 mins read
Bio Spectrum
August 2021

Stride Ventures leads Rs 25 Cr debt round in MediBuddy

Stride Ventures, one of India’s leading venture debt funds, has led a debt round of Rs 25 crore in Bengaluru-based startup MediBuddy that helps its users consult specialist doctors, order medicines and book lab tests from the comfort of their homes.

1 min read
Bio Spectrum
July 2021

‘‘We see growing interest of healthcare testing labs, Pharmaceutical QC and R&D labs in implementing next-gen lab automation solutions''

US-based Abbott Informatics, formerly known as STARLIMS, is one of the companies with a long and established presence in the space of lab automation. Taking pride in offering the world class technological solutions, the company has recently announced the launch of STARLIMS Quality Manufacturing Solution QM12.2 which is built on the latest STARLIMS Technology V12 platform, along with STARLIMS SDMS (Scientific Data Management System) V12.2. To find out more about the company’s automated offerings in India, BioSpectrum spoke to Pradeep Nagisetty, Regional Sales Manager - India & Sub Continent, Abbott Informatics - STARLIMS, Hyderabad.

5 mins read
Bio Spectrum
July 2021

‘Juvenile Idiopathic Arthritis' remains a puzzle

LET'S TALK HEALTH & SCIENCE

3 mins read
Bio Spectrum
July 2021

India proposes BRICS Consortium to tackle NCDs as flagship programme

Experts deliberated on emerging issues in the various fields of Biotechnology and Biomedicine at the fourth BRICS Working Group meeting on the subject area.

1 min read
Bio Spectrum
July 2021